Clinical trial
Serum DNA Analysis: Potential Application for Diagnosis and Prognosis in Brain…
NCT00265174 · Hadassah Medical Organization, Other · Unknown status
Key facts
| NCT number | NCT00265174 |
|---|---|
| Title | Serum DNA Analysis: Potential Application for Diagnosis and Prognosis in Brain Cancer. |
| Official title | Serum DNA Analysis: Potential Application for Diagnosis and Prognosis in Brain Cancer. |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Primary Brain Tumor |
| Enrollment | 60 |
| Start date | Jan 1, 2006 |
| First posted | Dec 14, 2005 |
| Last update posted | Dec 14, 2005 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: